KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Income (2016 - 2025)

Historic Net Income for Eli Lilly (LLY) over the last 16 years, with Q4 2025 value amounting to $6.6 billion.

  • Eli Lilly's Net Income rose 5052.16% to $6.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 9490.08%. This contributed to the annual value of $20.6 billion for FY2025, which is 9490.08% up from last year.
  • Latest data reveals that Eli Lilly reported Net Income of $6.6 billion as of Q4 2025, which was up 5052.16% from $5.6 billion recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Net Income peaked at $6.6 billion during Q4 2025, and registered a low of -$57.4 million during Q3 2023.
  • Moreover, its 5-year median value for Net Income was $1.8 billion (2022), whereas its average is $2.4 billion.
  • In the last 5 years, Eli Lilly's Net Income plummeted by 10395.4% in 2023 and then surged by 179041.81% in 2024.
  • Over the past 5 years, Eli Lilly's Net Income (Quarter) stood at $1.7 billion in 2021, then rose by 12.26% to $1.9 billion in 2022, then rose by 12.98% to $2.2 billion in 2023, then soared by 101.43% to $4.4 billion in 2024, then skyrocketed by 50.52% to $6.6 billion in 2025.
  • Its Net Income stands at $6.6 billion for Q4 2025, versus $5.6 billion for Q3 2025 and $5.7 billion for Q2 2025.